BioNTech SE(BNTX) - 2023 Q4 - Annual Report

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference call and webcast scheduled for March 20, 2024, at 8:00 a.m. ET (1:00 p.m. CET) "2023 was another year of good performance for BioNTech. We have maintained our leading position in the COVID-19 vaccine market which lays the foundation for establishing a sustainable respiratory vaccines business. In oncology, we have strengthened our core competencies by entering into several partnerships and have made numero ...